|
|
|
%20PRIVATE%20LIMITED%20-%20500482%2031-Mar-2018_files/image015.jpg){kind=small}
%20PRIVATE%20LIMITED%20-%20500482%2031-Mar-2018_files/image016.jpg)
%20PRIVATE%20LIMITED%20-%20500482%2031-Mar-2018_files/image018.gif)
MIRA INFORM REPORT
|
Report No. : |
500482 |
|
Report Date : |
31.03.2018 |
IDENTIFICATION DETAILS
|
Name : |
ALCON LABORATORIES (INDIA) PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
3rd Floor, Crescent – 4, Prestige Shanti Niketan, Whitefield,
Bangalore – 560048, Karnataka |
|
Tel. No.: |
91-80-40064600 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2017 |
|
|
|
|
Date of
Incorporation : |
21.07.1999 |
|
|
|
|
Com. Reg. No.: |
08-025496 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 1130.000 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U33119KA1999FTC025496 |
|
|
|
|
IEC No.: [Import-Export Code No.] |
Not Divulged |
|
|
|
|
PAN No.: [Permanent Account No.] |
AACCA3430F |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Divulged |
|
|
|
|
GSTN : [Goods & Service Tax
Registration No.] |
29AACCA3430F1Z2 |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
The Company offers the widest spectrum of eye care products in surgical and pharmaceutical business. The Company is in the business of trading Alcon Group’s products in India, provides services in relation to maintenance of the products and also support services to group companies. (Registered Activity) |
|
|
|
|
No. of Employees
: |
Not Divulged |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
B |
|
Credit Rating |
Explanation |
Rating Comments |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject was incorporated in the year 1999. It is a subsidiary of Novartis AG, Switzerland. As per the financial records of 2017, the company has achieved a minimal growth in its revenue as compared to the previous year’s revenue but has incurred net losses. The weak financial position of the company is marked by huge accumulated losses which have eroded the net worth base. Rating takes into consideration the strength that the company derives from its holding company and its experienced management team and the subject’s long established track record. Business is active. Payment seems to be slow but correct. In view of aforesaid, the company can be considered for business dealings with some caution. Note : As a Networth of the company is negative, we are unable to recommend any credit limit for the subject |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2017) |
Current Rating (31.12.2017) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
Not Available |
|
Rating |
Not Available |
|
Rating Explanation |
Not Available |
|
Date |
Not Available |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 31.03.2018
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION DECLINED
Management non-cooperative (Tel No.: 91-80-40064600)
LOCATIONS
|
Registered Office : |
3rd Floor, Crescent – 4, Prestige Shanti Niketan, Whitefield,
Bangalore – 560048, Karnataka, India |
|
Tel. No.: |
91-80-40064600 |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Sales Office: |
Plot # 210, Ground Floor, Okhla Industrial Estate, Phase III, New Delhi-110020, India |
|
Tel. No.: |
91-11-4749 4600 |
DIRECTORS
As on 31.03.2017
|
Name : |
Mr. Sanjeev Shrivastav |
||||||||
|
Designation : |
Director |
||||||||
|
Address : |
Flat No.- 301, A-Wing, Caviana, Hiranandani Estate Patlipada, G.B
Road, Thane-400607, Maharashtra, India |
||||||||
|
Date of Appointment : |
10.05.2017 |
||||||||
|
DIN No.: |
02631846 |
||||||||
|
Other
Directorship:
|
|||||||||
|
|
|
||||||||
|
Name : |
Mr. Vijayanarayanan |
||||||||
|
Designation : |
Director |
||||||||
|
Address : |
702, Hercules, Lodha Paradise, Near Majewada Flyover, Eastern Express Highway,
Thane (West), Thane-400601, Maharashtra, India |
||||||||
|
Date of Appointment : |
10.05.2017 |
||||||||
|
DIN No.: |
06639177 |
||||||||
|
|
|
||||||||
|
Name : |
Mr. Rajkumar Narayanan |
||||||||
|
Designation : |
Director |
||||||||
|
Address : |
9 Barcelona Irvine California 92614 US |
||||||||
|
Date of Appointment : |
22.09.2017 |
||||||||
|
DIN No.: |
07013882 |
||||||||
|
|
|
||||||||
|
Name : |
Mr. Sunil Vasanth Dhotre |
||||||||
|
Designation : |
Director |
||||||||
|
Address : |
C 18 Fair Lawn Apartments Sion, Trombay Road, Chembur, Mumbai-400071,
Maharashtra, India |
||||||||
|
Date of Birth/Age : |
23.06.1969 |
||||||||
|
Date of Appointment : |
15.04.2016 |
||||||||
|
DIN No.: |
07485144 |
||||||||
|
Other
Directorship:
|
|||||||||
KEY EXECUTIVES
|
Name : |
Mr. Omkar Nagesh Gayatri |
|
Designation : |
Company Secretary |
|
Address : |
Plot No 18B Whiterose Layout, Whitefield Bangalore 560066, Karnataka, India |
|
Date of Appointment : |
24.01.2017 |
|
PAN No.: |
AMYPG5389G |
MAJOR SHAREHOLDERS
As on 31.03.2017
|
Names of Shareholders |
|
No. of Shares |
|
Novartis AG, Switzerland |
|
112995337 |
|
Alcon Pharmaceutical Limited, Switzerland |
|
1 |
|
Total |
|
112995338 |
Equity Share Break up (Percentage of Total Equity)
As on 26.09.2017
|
Category |
Percentage |
|
Promoters (Body corporate) |
100.00 |
|
Total |
100.00 |
%20PRIVATE%20LIMITED%20-%20500482%2031-Mar-2018_files/image020.gif)
BUSINESS DETAILS
|
Line of Business : |
The Company offers the widest spectrum of eye care products in surgical and pharmaceutical business. The Company is in the business of trading Alcon Group’s products in India, provides services in relation to maintenance of the products and also support services to group companies. (Registered Activity) |
||||||||||||||||
|
|
|
||||||||||||||||
|
Products / Services
: |
|
||||||||||||||||
|
|
|
||||||||||||||||
|
Brand Names : |
Not Available |
||||||||||||||||
|
|
|
||||||||||||||||
|
Agencies Held : |
Not Available |
||||||||||||||||
|
|
|
||||||||||||||||
|
Exports : |
Not Divulged |
||||||||||||||||
|
|
|
||||||||||||||||
|
Imports : |
Not Divulged |
||||||||||||||||
|
|
|
||||||||||||||||
|
Terms : |
Not Divulged |
PRODUCTION STATUS – (NOT AVAILABLE)
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
Not Divulged |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
|
Auditors : |
|
|
Name : |
Price Waterhouse and Company LLP Chartered Accountants |
|
Address : |
5th Floor, Tower D, The Millenia, 1 and 2 Murphy Road, Ulsoor, Bangalore -560008, Karnataka, India |
|
Income-tax
PAN of auditor or auditor's firm : |
AAHFP0187A |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Holding company : |
Novartis AG, Switzerland |
|
|
|
|
Fellow Subsidiary
Companies : |
· Alcon Laboratories Inc. · Alcon Research Limited · Sandoz Private Limited · Novartis Asia Pacific Pharmaceuticals Pte. Limited · Alcon Laboratories (Phil) Inc. · Alcon Pharma GmbH · Befico Limited · Chiron Behring Vaccines Private Limited · Alcon Farmacevtika LLC · Novartis Healthcare Private Limited · Novartis Pharma AG · Novartis Healthcare Private Limited · Novartis India Limited · Novartis International AG · Laboratories Alcon SA · Wavelight GmbH |
CAPITAL STRUCTURE
As on 26.09.2017
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
113500000 |
Equity Shares |
INR 10/- each |
INR 1135.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
112995338 |
Equity Shares |
INR 10/- each |
INR 1129.953 Million |
|
|
|
|
|
As on 31.03.2017
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
113500000 |
Equity Shares |
INR 10/- each |
INR 1135.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
113000000 |
Equity Shares |
INR 10/- each |
INR 1130.000 Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
INR Million]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
1130.000 |
1130.000 |
1130.000 |
|
(b) Reserves and Surplus |
(1319.900) |
(1218.900) |
259.000 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
(189.900) |
(88.900) |
1389.000 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Deferred tax liabilities (Net) |
0.000 |
0.000 |
0.000 |
|
(c) Other long-term
liabilities |
133.700 |
291.500 |
520.200 |
|
(d) long-term
provisions |
301.100 |
193.100 |
163.800 |
|
Total Non-current
Liabilities (3) |
434.800 |
484.600 |
684.000 |
|
|
|
|
|
|
(4)
Current Liabilities |
|
|
|
|
(a) Short-term
borrowings |
4695.400 |
5814.300 |
5124.900 |
|
(b) Trade
payables |
2884.000 |
3070.500 |
3310.700 |
|
(c) Other
current liabilities |
550.400 |
633.600 |
716.400 |
|
(d) Short-term
provisions |
628.800 |
181.200 |
81.100 |
|
Total Current Liabilities
(4) |
8758.600 |
9699.600 |
9233.100 |
|
|
|
|
|
|
TOTAL |
9003.500 |
10095.300 |
11306.100 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
277.100 |
340.400 |
481.200 |
|
(ii)
Intangible Assets |
0.200 |
1.200 |
2.500 |
|
(iii) Tangible assets
capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
(iv)
Intangible assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
0.000 |
0.000 |
0.000 |
|
(c) Deferred tax assets (net) |
1114.800 |
969.100 |
124.400 |
|
(d)
Long-term loans and advances |
744.000 |
761.300 |
50.400 |
|
(e) Other
Non-current assets |
866.000 |
1686.300 |
2688.700 |
|
Total Non-Current
Assets |
3002.100 |
3758.300 |
3347.200 |
|
|
|
|
|
|
(2)
Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
0.000 |
0.000 |
|
(b)
Inventories |
2598.200 |
2866.400 |
2905.600 |
|
(c) Trade
receivables |
3271.300 |
3357.000 |
4567.100 |
|
(d) Cash and
bank balances |
6.600 |
8.000 |
10.100 |
|
(e)
Short-term loans and advances |
122.500 |
98.500 |
474.100 |
|
(f) Other
current assets |
2.800 |
7.100 |
2.000 |
|
Total
Current Assets |
6001.400 |
6337.000 |
7958.900 |
|
|
|
|
|
|
TOTAL |
9003.500 |
10095.300 |
11306.100 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
SALES |
|
|
|
|
|
Revenue
from operations |
8445.500 |
8363.300 |
9389.600 |
|
|
Other Income |
12.900 |
2.600 |
21.300 |
|
|
TOTAL |
8458.400 |
8365.900 |
9410.900 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials
Consumed |
325.900 |
324.000 |
288.500 |
|
|
Purchases of
Stock-in-Trade |
3721.100 |
4224.200 |
6005.900 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
268.200 |
39.200 |
(688.400) |
|
|
Employee benefit expense |
1371.000 |
1269.300 |
1381.100 |
|
|
CSR expenditure |
0.000 |
0.000 |
1.600 |
|
|
Other expenses |
2012.300 |
2044.700 |
1789.400 |
|
|
Extraordinary items |
0.000 |
2004.300 |
0.000 |
|
|
TOTAL |
7698.500 |
9905.700 |
8778.100 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
759.900 |
(1539.800) |
632.800 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
479.800 |
474.400 |
466.800 |
|
|
|
|
|
|
|
|
PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
280.100 |
(2014.200) |
166.000 |
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
130.000 |
181.500 |
145.700 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS) BEFORE
TAX |
150.100 |
(2195.700) |
20.300 |
|
|
|
|
|
|
|
Less |
TAX |
251.100 |
(717.800) |
121.200 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
AFTER TAX |
(101.000) |
(1477.900) |
(100.900) |
|
|
|
|
|
|
|
Add |
PREVIOUS YEARS’ BALANCE BROUGHT FORWARD |
(1218.900) |
259.000 |
359.900 |
|
|
|
|
|
|
|
|
Balance
Carried to the B/S |
(1319.900) |
(1218.900) |
259.000 |
|
|
|
|
|
|
|
|
Earnings / (Loss) Per
Share (INR) |
(0.89) |
(13.08) |
(0.89) |
CURRENT MATURITIES
OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Maturities of Long term debt |
NA |
NA |
NA |
|
Cash generated from operations |
NA |
NA |
NA |
|
Net cash flows from (used in) operations |
1708.500 |
2664.200 |
(107.400) |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Average Collection Days (Sundry Debtors / Income * 365 Days) |
141.38 |
146.51 |
177.54 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry
Debtors) |
2.58 |
2.49 |
2.06 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors
/ Purchases * 365 Days) |
260.11 |
246.41 |
191.98 |
|
|
|
|
|
|
Inventory Turnover (Operating Income
/ Inventories) |
0.29 |
(0.54) |
0.22 |
|
|
|
|
|
|
Asset Turnover (Operating Income
/ Net Fixed Assets) |
2.74 |
(4.51) |
1.31 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Debt Ratio ((Borrowing + Current Liabilities) / Total
Assets) |
0.97 |
0.96 |
0.82 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability
/ Networth) |
(24.73) |
(65.40) |
3.69 |
|
|
|
|
|
|
Current Liabilities to Networth (Current
Liabilities / Net Worth) |
(46.12) |
(109.11) |
6.65 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets
/ Networth) |
(1.46) |
(3.84) |
0.35 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial
Charges) |
1.58 |
(3.25) |
1.36 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Net Profit Margin ((PAT / Sales) *
100) |
% |
(1.20) |
(17.67) |
(1.07) |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total
Assets) * 100) |
% |
(1.12) |
(14.64) |
(0.89) |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth)
* 100) |
% |
53.19 |
1662.43 |
(7.26) |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Ratio (Current Assets / Current Liabilities) |
0.69 |
0.65 |
0.86 |
|
|
|
|
|
|
Quick Ratio ((Current Assets –
Inventories) / Current Liabilities) |
0.39 |
0.36 |
0.55 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total
Assets) |
(0.02) |
(0.01) |
0.12 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity
Capital) |
4.16 |
5.15 |
4.54 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current
Assets / Total Current Liabilities) |
0.69 |
0.65 |
0.86 |
Total Liability = Short-term Debt + Long-term
Debt + Current Maturities of Long-term debts
FINANCIAL ANALYSIS
[all figures are
in INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Share Capital |
1130.000 |
1130.000 |
1130.000 |
|
Reserves & Surplus |
259.000 |
(1218.900) |
(1319.900) |
|
Net worth |
1389.000 |
(88.900) |
(189.900) |
|
|
|
|
|
|
long-term borrowings |
0.000 |
0.000 |
0.000 |
|
Short term borrowings |
5124.900 |
5814.300 |
4695.400 |
|
Total
borrowings |
5124.900 |
5814.300 |
4695.400 |
|
Debt/Equity
ratio |
3.690 |
(65.403) |
(24.726) |
%20PRIVATE%20LIMITED%20-%20500482%2031-Mar-2018_files/image022.gif)
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
9389.600 |
8363.300 |
8445.500 |
|
|
|
(10.930) |
0.983 |
%20PRIVATE%20LIMITED%20-%20500482%2031-Mar-2018_files/image024.gif)
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
9389.600 |
8363.300 |
8445.500 |
|
Profit/ (Loss) |
(100.900) |
(1477.900) |
(101.000) |
|
(1.07%) |
(17.67%) |
(1.20%) |
%20PRIVATE%20LIMITED%20-%20500482%2031-Mar-2018_files/image026.gif)
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of establishment |
Yes |
|
2] |
Constitution of the entity Incorporation
details |
Yes |
|
3] |
Locality of the entity |
Yes |
|
4] |
Premises details |
No |
|
5] |
Buyer visit details |
-- |
|
6] |
Contact numbers |
Yes |
|
7] |
Name of the person contacted |
No |
|
8] |
Designation of contact person |
No |
|
9] |
Promoter’s background |
Yes |
|
10] |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11] |
Pan Card No. of Proprietor / Partners |
No |
|
12] |
Voter Id Card No. of Proprietor / Partners |
No |
|
13] |
Type of business |
Yes |
|
14] |
Line of Business |
Yes |
|
15] |
Export/import details (if applicable) |
No |
|
16] |
No. of employees |
No |
|
17] |
Details of sister concerns |
Yes |
|
18] |
Major suppliers |
No |
|
19] |
Major customers |
No |
|
20] |
Banking Details |
No |
|
21] |
Banking facility details |
Yes |
|
22] |
Conduct of the banking account |
-- |
|
23] |
Financials, if provided |
Yes |
|
24] |
Capital in the business |
Yes |
|
25] |
Last accounts filed at ROC, if applicable |
Yes |
|
26] |
Turnover of firm for last three years |
Yes |
|
27] |
Reasons for variation <> 20% |
-- |
|
28] |
Estimation for coming financial year |
No |
|
29] |
Profitability for last three years |
Yes |
|
30] |
Major shareholders, if available |
Yes |
|
31] |
External Agency Rating, if available |
No |
|
32] |
Litigations that the firm/promoter
involved in |
-- |
|
33] |
Market information |
-- |
|
34] |
Payments terms |
No |
|
35] |
Negative Reporting by Auditors in the
Annual Report |
No |
NOTE: Registered office of the company has been
shifted from Unit No. 502, 5th Floor, Tower D, RMZ Infinity, Benniganahalli,
Old Madras Road, Bangalore – 560016, Karnataka, India to the present address w.e.f. 16.11.2012
GENERAL INFORMATION
The Company was incorporated on July 21, 1999 as a private limited company under the Companies Act, 1956 (‘the Act’) having its registered office in Bangalore, Karnataka, India.
The Company offers the widest spectrum of eye care products in surgical and pharmaceutical business. The Company is in the business of trading Alcon Group’s products in India, provides services in relation to maintenance of the products and also support services to group companies.
REVIEW OF BUSINESS
OPERATIONS
Current Financial Year was challenging on account of intense competetion and regulatory developments proposed. During the year, there is an increase in sale of the equipment due to higher number of deals as compared to previous years
UNSECURED LOAN
|
PARTICULAR |
31.03.2017 (INR
in Million) |
31.03.2016 (INR
in Million) |
|
Long-term
Borrowings |
|
|
|
Rupee term loans from banks |
3000.000 |
3080.000 |
|
Loans repayable on demand from banks |
1695.400 |
2734.300 |
|
Total |
4695.400 |
5814.300 |
INDEX OF CHARGES: NO
CHARGES EXISTS FOR COMPANY
FIXED ASSETS
- Plant and equipment
- Furniture and fixtures
- Vehicles
- Office equipment
- Computer equipments
- Leasehold improvements
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market survey
revealed that the amount of compensation sought by the subject is fair and
reasonable and comparable to compensation paid to others for similar services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 65.04 |
|
UK Pound |
1 |
INR 92.28 |
|
Euro |
1 |
INR 80.62 |
INFORMATION DETAILS
|
Information
Gathered by : |
SUP |
|
|
|
|
Analysis Done by
: |
NIY |
|
|
|
|
Report Prepared
by : |
JYTK |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.
·